Pluvicto 00078-1217

Generic: Lutetium Lu 177 Vipivotide Tetraxetan

Product NDC

00078-1217

Manufacturer: Novartis Pharmaceuticals Corporation
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: March 23, 2022
Listing Expires: December 31, 2027
Application: NDA215833

Need to source Pluvicto? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Lutetium Lu-177 Vipivotide Tetraxetan	27 mCi/mL

Drug Class

Radioligand Therapeutic Agent [EPC]Radioligand Activity [MoA]Radioligand Therapeutic Agent [EPC]

Packaging Options(1)

00078-1217-61

1 VIAL, GLASS in 1 PACKAGE (0078-1217-61) / 7.5 mL in 1 VIAL, GLASS

View →